Advertisement

Atropine Sulfate Injection

[06 April 2016]

Products Affected - Description

Atropine Sulfate injection, American Regent
0.4 mg/mL, 1 mL single dose vial, 25 count (NDC 00517-0401-25)

Reason for the Shortage

  • Amphastar had atropine on shortage due to increased demand.
  • Hospira states the shortage was due to manufacturing delays.

Available Products

Atropine Sulfate injection, American Regent
1 mg/mL, 1 mL single dose vial, 25 count (NDC 00517-1010-25)
 
Atropine Sulfate injection, Amphastar
0.1 mg/mL, 10 mL Luer-Jet syringe, 10 count (NDC 76329-3339-01)

Atropine Sulfate injection, Hospira
0.05 mg/mL, 5 mL Ansyr syringe, 10 count (NDC 00409-9630-05)
0.1 mg/mL, 5 mL LifeShield syringe, 10 count (NDC 00409-4910-34)
0.1 mg/mL, 10 mL Ansyr syringe, 10 count (NDC 00409-1630-10)
0.1 mg/mL, 10 mL 21 gauge LifeShield syringe, 10 count (NDC 00409-4911-34)
 
Atropine Sulfate injection, West-Ward
0.4 mg/mL, 20 mL multi-dose vial, 10 count (NDC 00641-6006-10)

Estimated Resupply Dates

American Regent has atropine 0.4 mg/mL 1 mL ampules available in limited supply.

Updated

April 6, January 29, 2016; December 23 and 10, November 18, October 15, September 17, August 11 and 4, July 10, June 8, May 5, February 16, January 9, 2015; December 2, November 19, October 21 and 15, September 3, August 28, July 21, June 16, April 22, February 11, 2014; December 9, November 20 and 5, October 7, September 16, August 30, July 11, June 19 and 4, May 14, April 22 and 10, March 14, January 22 and 2, 2013; November 8, September 14, June 29, 21 and 1, May 2, April 10, March 29 and 23, January 27, 2012; December 20 and 16, November 29 and 9, October 20, September 14, August 19 and 2, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing